The temperature-sensitive mutants of Toxoplasma gondii and ocular toxoplasmosis

Vaccine

Volumn 27, Issue 4, 2009, Pages 573-580

  Lu, Fangli ^a   Huang, Shiguang ^b   Kasper, Lloyd H ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Eye; Mice; Toxoplasma gondii; Vaccine

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; PROTOZOAL VACCINE; TOXOPLASMOSIS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; C57BL 6 MOUSE; CD4 CD8 RATIO; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EYE INFECTION; FEMALE; HISTOPATHOLOGY; IMMUNOREACTIVITY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; TACHYZOITE; TEMPERATURE SENSITIVE MUTANT; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EYE; FIBROBLASTS; HUMANS; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; PROTOZOAN VACCINES; TEMPERATURE; TOXOPLASMA; TOXOPLASMOSIS, OCULAR;

EID: 57749195094     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.090     Document Type: Article

References (32)

1. Montoya J.G., and Liesenfeld O. Toxoplasmosis. Lancet 363 (2004) 1965-1976
2. Roberts F., and McLeod R. Pathogenesis of toxoplasmic retinochoroiditis. Parasitol Today 15 2 (1999) 51-57
3. Gilbert R.E., Dunn D.T., Lightman S., Murray P.I., Pavesio C.E., Gormley P.D., et al. Incidence of symptomatic toxoplasma eye disease: etiology and public health implications. Epidemiol Infect 123 (1999) 283-289
4. Atmaca L.S., Simsek T., and Batioglu F. Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol 48 (2004) 386-391
5. Gaddi P.J., and Yap G.S. Cytokine regulation of immunopathology in toxoplasmosis. Immunol Cell Biol 85 (2007) 155-159
6. Araujo F.G. Immunization against Toxoplasma gondii. Parasitol Today 10 (1994) 358-360
7. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 146 (1991) 286-292
8. Hu M.S., Schwartzman J.D., Lepage A.C., Khan I.A., and Kasper H.L. Experimental OT induced in naive and preinfected mice by intracameral inoculation. Ocul Immunol Inflamm 7 (1999) 17-26
9. + T cells in the pathogenesis of murine ocular toxoplasmosis. Infect Immun 72 (2004) 4966-4972
10. Waldeland H., Pfefferkorn E.R., and Frenkel J.K. Temperature sensitive mutants of Toxoplasma gondii: pathogenicity and persistence in mice. J Parasitol 69 (1983) 171-175
11. Sayles P.C., and Johnson L.L. Intact immune defenses are required for mice to resist the ts-4 vaccine strain of Toxoplasma gondii. Infect Immun 64 (1996) 3088-3092
12. Pinckney R.D., Lindsay D.S., and Blagburn B.L. Further characterization of the TS-4 temperature-sensitive mutant of Toxoplasma gondii in mice. J Parasitol 81 (1995) 118-121
13. Lindsay D.S., Blagburn B.L., and Dubey J.P. Safety and results of challenge of weaned pigs given a temperature-sensitive mutant of Toxoplasma gondii. J Parasitol 79 (1993) 71-76
14. Lu F., Huang S., Hu M.S., and Kasper L.H. Experimental ocular toxoplasmosis in genetically susceptible and resistant mice. Infect Immun 73 (2005) 5160-5165
15. Pinckney R.D., Lindsay D.S., Blagburn B.L., Boosinger T.R., McLaughlin S.A., and Dubey J.P. Evaluation of the safety and efficacy of vaccination of nursing pigs with living tachyzoites of two strains of Toxoplasma gondii. J Parasitol 80 (1994) 438-448
16. Lu F., Huang S., and Kasper L.H. Interleukin-10 and pathogenesis of murine OT. Infect Immun 71 (2003) 7159-7163
17. + T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J Immunol 147 (1991) 2310-2316
18. + T cell responses in efferent lymph responding to Toxoplasma gondii infection: analysis of phenotype and function. Parasite Immunol 17 (1995) 151-160
19. Khan I.A., Smith K.A., and Kasper L.H. Induction of antigen specific parasiticidal cytotoxic T-cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii. J Immunol 141 (1988) 3600-3605
20. + cytotoxic cells. J Parasitol 75 (1989) 411-416
21. + T lymphocytes are the major cell population involved in the early gamma interferon response and resistance to acute primary Toxoplasma gondii infection in mice. Microbiol Immunol 38 (1994) 789-796
22. + T cells in mice. J Immunol 140 (1988) 3943-3946
23. Johnson L.L., and Sayles P.C. Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice. Infect Immun 70 (2002) 185-191
24. + T cells to control acute Toxoplasma gondii infection. Infect Immun 71 (2003) 309-316
25. Gazzinelli R.T., Brezin A., Li Q., Nussenblatt R.B., and Chan C.C. Toxoplasma gondii: acquired OT in the murine model, protective role of TNF-α and IFN-γ. Exp Parasitol 78 (1994) 217-229
26. Liesenfeld O., Kosek J., Remington J.S., and Suzuki Y. Association of CD4 T-cell dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med 184 (1996) 597-607
27. Garweg J.G., and Boehnke M. The antibody response in experimental ocular toxoplasmosis. Graefes Arch Clin Exp Ophthalmol 244 (2006) 1668-1679
28. Sayles P.C., Gibson G.W., and Johnson L.L. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect Immun 68 (2000) 1026-1033
29. Kang H., Remington J.S., and Suzuki Y. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-γ, TNF-α, and inducible nitric oxide synthase. J Immunol 164 (2000) 2629-2634
30. Couper K.N., Roberts C.W., Brombacher F., Alexander J., and Johnson L.L. Toxoplasma gondii-specific immunoglobulin M limits parasite dissemination by preventing host cell invasion. Infect Immun 73 (2005) 8060-8068
31. Harris D.P., Haynes L., Sayles P.C., Duso D.K., Eaton S.M., Lepak N.M., et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 1 (2000) 475-482
32. Menard LC, Minns LA, Darche S, Mielcarz DW, Foureau DM, Roos D, Dzierszinski F, Kasper LH, Buzoni-Gatel D. B cells amplify IFN-gamma production by T cells via a TNF-alpha-mediated mechanism. J Immunol 2007; 179(7):4857-66.